4G/5G Polymorphism of Plasminogen Activator Inhibitor-1(PAI-1) Gene in Polycystic Ovarian Syndrome and Its Correlation with Glucose Metabolism and Obese Status

Junli Zhao
2006-01-01
Abstract:Objective:To investigate the correlation of 4G/5G polymorphism of plasminogen activator inhibitor-1(PAI-1) gene with the glucose metabolism and obese status of polycystic ovary syndrome(PCOS).Methods:4G/5G polymorphism of PAI-1 gene was detected by PCR-RFLP method in 42 controls and 101 PCOS patients who were divided into three groups:normal glucose tolerance without or with hyperinsulinemia(group A and B) and abnormal glucose tolerance group(group C).Body Mass Index(BMI),insulin resistance(Homa-IR) and insulin sensitivity indices(ISI) are compared between the groups.Results:In PCOS patients,BMI,Homa-IR were significantly higher in group C than those of group B and group A.BMI and Homa-IR were higher in obese PCOS than those in non-obese PCOS,while ISI is just the opposite.(P0.05).The distribution of PAI-1 gene genotype between PCOS and control,C subgroup and control and between non-obese and obese PCOS group are different(χ~2=4.439;(4.018);4.012;P0.05):4G genetype(4G/4G genotype) is higher and 5G genetype(5G/5G and 4G/5G genotype) were lower in PCOS group,PCOS subgroup C and non-obese PCOS group than that of each control group.Conclusions:High expression of 4G/4G genotype in PAI-1 gene 4G/5G polymorphism may play an important genetic role in the increased PAI1 levels in PCOS patients.It may also be correlated with abnormal glucose metabolism in PCOS patients and the development of PCOS especially in non-obese patients.
What problem does this paper attempt to address?